Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11- deoxygalactonojirimycin----1件: 19 💬
21-deoxygalactonojirimycin hydrochloride1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
312 lead electrocardiogram----1件: 19 💬
412S-IT----1件: 19 💬
515-0 H20----2件: 6, 19 💬
61629063-78-0----1件: 19 💬
72(S)-(acetylamino)-4-methylpentanoic acid----2件: 19, 65 💬
82-aminoethanethiol1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--2件: 19, 299 💬
92-hour holter monitor----1件: 19 💬
102-hydroxypropyl-BETA-cyclodextrin1件: Hydroxypropyl betadex---1件: 19 💬
1126 common fabry mutation types IN taiwan----1件: 19 💬
124D-3101件: 4D-310---1件: 19 💬
13500 0500 0----1件: 19 💬
1468GA-dotatate PET/MRI1件: Dotatate gallium Ga-681件: Edotreotide gallium Ga-68 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 19 💬
1589ZR-SBC-1031件: Lesinidase alfa1件: Lesinidase alfa 💬 1件: NAGLU 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
16A16ax06----1件: 19 💬
17AAV2/8.TBG.harsb----1件: 19 💬
18AAV9-CAG-COH-sgsh----1件: 19 💬
19AAV9-GLB1----1件: 19 💬
20Aavrh.10-hmpsiiia----1件: 19 💬
21Aavrh.10cuarsa----1件: 19 💬
22Aavrh.10cucln2----1件: 19 💬
23Aavrh.10cuhcln2 vector 2.85x10^11 genome copies----1件: 19 💬
24Aavrh.10cuhcln2 vector 9.0x10^11 genome copies----1件: 19 💬
25Abatacept1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬26件: 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
26Abcertin----1件: 19 💬
27Abdominal ultrasound----2件: 19, 231 💬
28ABO-101----2件: 19, 234 💬
29ABO-1021件: Rebisufligene etisparvovec---1件: 19 💬
30Accupro----1件: 19 💬
31Accuretic----1件: 19 💬
32Acetaminophen1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬14件: 11, 19, 34, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
33ACT-434964----1件: 19 💬
34Adalimumab1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬18件: 19, 37, 40, 41, 46, 55, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬
35Adeno-associated viral (AAV) serotype 8 (AAV2/8) vector with liver-specific thyroxine-binding globulin (TBG) promoter, driving THE expression OF THE human arsb gene----1件: 19 💬
36Adeno-associated viral vector serotype 9 containing THE human N-acetyl-alpha-glucosaminidase gene----1件: 19 💬
37Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cdna----1件: 19 💬
38Adeno-associated virus serotype 2/6 encoding human iduronate 2-sulfatase (hids) gene donor vector, SB-A6P-HNT donor vector----1件: 19 💬
39Adeno-associated virus serotype 2/6 encoding left SIDE-zinc finger nuclease (ZFN1), SB-A6P-zleft vector----1件: 19 💬
40Adeno-associated virus serotype 2/6 encoding right SIDE-zinc finger nuclease (ZFN2), SB-A6P-zright vector----1件: 19 💬
41Adeno-associated virus serotype HU68 containing THE human galc gene----1件: 19 💬
42Adeno-associated virus serotype RH.10 expressing BETA-galactosidase----1件: 19 💬
43Adjuvant IM therapy----1件: 19 💬
44Adjuvant immunomodulatory (IM) therapy----1件: 19 💬
45Administration KIT----1件: 19 💬
46Adrabetadex1件: Adrabetadex---1件: 19 💬
47Afegostat tartrate1件: Afegostat2件: Afegostat ,
Afegostat tartrate 💬 		--1件: 19 💬
48Agalsidase----1件: 19 💬
49Agalsidase alfa1件: Agalsidase alfa1件: Agalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
50Agalsidase alpha1件: Agalsidase alfa1件: Agalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
51Agalsidase beta1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
52Agalsidase beta from biosidus 1 MG/KG1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
53Agalsidasi alfa----1件: 19 💬
54Agalsidasi beta----1件: 19 💬
55AGT-181----1件: 19 💬
56AGT-1821件: AGT-182---1件: 19 💬
57AL01211----2件: 19, 67 💬
58Aldurazyme1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome 💬2件: 19, 256 💬
59Aldurazyme*infus 1FL 5ML 500U1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
60Alemtuzumab1件: Alemtuzumab1件: Alemtuzumab 💬 --18件: 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 65, 85, 96, 107, 283, 284, 285, 326 💬
61Alendronate sodium1件: Alendronic acid2件: Alendronate sodium ,
Alendronic acid 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬2件: 19, 299 💬
62ALFA-manosidadas humana recombinante----1件: 19 💬
63Allogeneic stem cell transplantation----5件: 19, 20, 49, 62, 84 💬
64Ambroxol1件: Ambroxol2件: Ambroxol hydrochloride ,
Ambroxol 💬 		--3件: 2, 6, 19 💬
65Ambroxol hydrochloride1件: Ambroxol2件: Ambroxol hydrochloride ,
Ambroxol 💬 		--2件: 6, 19 💬
66Ambroxol hydrochloride 30 MG tablet - 18 MG/KG/DAY1件: Ambroxol2件: Ambroxol hydrochloride ,
Ambroxol 💬 		--1件: 19 💬
67Ambroxol hydrochloride 30 MG tablet - 27 MG/KG/DAY1件: Ambroxol2件: Ambroxol hydrochloride ,
Ambroxol 💬 		--1件: 19 💬
68Ambroxol hydrochloride 30 MG tablet - 9 MG/KG/DAY1件: Ambroxol2件: Ambroxol hydrochloride ,
Ambroxol 💬 		--1件: 19 💬
69AMT-191----1件: 19 💬
70Anakinra1件: Anakinra1件: Anakinra 💬 2件: IL1R1,
IL1R2 💬 		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬19件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬
71Antihistamine----3件: 13, 19, 46 💬
72Antipyretic----2件: 19, 257 💬
73Arimoclomol1件: Arimoclomol2件: Arimoclomol ,
Arimoclomol citrate 💬 		--3件: 2, 15, 19 💬
74Arimoclomol citrate1件: Arimoclomol2件: Arimoclomol ,
Arimoclomol citrate 💬 		--2件: 15, 19 💬
75Arylsulfatase A----1件: 19 💬
76AT-GTX-501----1件: 19 💬
77AT1001----1件: 19 💬
78AT1001 150 MG----1件: 19 💬
79AT2101----1件: 19 💬
80Ataluren1件: Ataluren1件: Ataluren 💬 --6件: 19, 113, 140, 246, 299, 329 💬
81ATG----6件: 13, 19, 60, 96, 222, 285 💬
82Audiology assessment with ABR----1件: 19 💬
83Autologous CD34+ cells transduced with A lentiviral vector containing THE human sgsh gene----1件: 19 💬
84Autologous CD34+ cells transduced with A lentiviral vector encoding THE arsa cdna----1件: 19 💬
85Autologous CD34+ hscs transduced EX vivo with CD11B LV encoding human IDS tagged with apoeii----1件: 19 💬
86Autologous plasmablasts----1件: 19 💬
87AVR-RD-011件: AVR-RD-01---1件: 19 💬
88AVR-RD-021件: AVR-RD-02---1件: 19 💬
89AX 250----1件: 19 💬
90AXO-AAV-GM21件: Cobnabexagene anvuparvovec---1件: 19 💬
91AXO-AAV-GM2 high dose1件: Cobnabexagene anvuparvovec---1件: 19 💬
92AXO-AAV-GM2 LOW dose1件: Cobnabexagene anvuparvovec---1件: 19 💬
93AXO-AAV-GM2 middle dose1件: Cobnabexagene anvuparvovec---1件: 19 💬
94AXO-AAV-GM2 starting dose1件: Cobnabexagene anvuparvovec---1件: 19 💬
95AZ-31021件: AZ-3102---1件: 19 💬
96Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--22件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
97BBM-F101 injection----1件: 19 💬
98Biological assays----1件: 19 💬
99Blood draw----7件: 6, 19, 65, 67, 96, 231, 299 💬
100Blood sampling FOR biological and genetic analysis----1件: 19 💬
101BM110----1件: 19 💬
102BMN 110----1件: 19 💬
103BMN 110 - every other week----1件: 19 💬
104BMN 110 - weekly----1件: 19 💬
105BMN 110 every other week----1件: 19 💬
106BMN 110 weekly----1件: 19 💬
107BMN 190----1件: 19 💬
108BMN 250----1件: 19 💬
109Brain MRI/MRS/fmri----1件: 19 💬
110Brief pain inventory questionnaire----1件: 19 💬
111Brineura1件: Cerliponase alfa1件: Cerliponase alfa 💬 1件: TPP1 💬 1件: Lysosome 💬1件: 19 💬
112Busilvex1件: Busulfan1件: Busulfan 💬 --4件: 19, 36, 60, 65 💬
113Busilvex - 6 MG/ML - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino - 10 ML 8 flaconcini1件: Busulfan1件: Busulfan 💬 --2件: 19, 65 💬
114Busulfan1件: Busulfan1件: Busulfan 💬 --14件: 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
115Busulfan, cyclophosphamide, antithymocyte globulin1件: Busulfan1件: Busulfan 💬 --2件: 19, 20 💬
116Busulfan, cyclophosphamide, ATG1件: Busulfan1件: Busulfan 💬 --1件: 19 💬
117Busulfano1件: Busulfan1件: Busulfan 💬 --1件: 19 💬
118Calcium carbonate2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--7件: 13, 19, 46, 75, 96, 235, 299 💬
119Campath-1H1件: Alemtuzumab1件: Alemtuzumab 💬 --6件: 19, 20, 60, 65, 234, 326 💬
120Cannabidiol1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬18件: 6, 8, 13, 19, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 271 💬
121Cannabis sativa L., folium CUM flore1件: Medical Cannabis1件: Cannabis 💬 --1件: 19 💬
122Cebsulfase alfa----1件: 19 💬
123Cellule CD34+ autologhe trasdotte CON idua LV codificante PER IL cdna dell'ALFA-L-iduronidasi----1件: 19 💬
124Cerdelga1件: Eliglustat2件: Eliglustat ,
Eliglustat tartrate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
125Cerezyme1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬 		1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
126Cerezyme 400 units powder FOR concentrate FOR solution FOR infusion1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬 		1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
127Cerezyme 400 unità polvere PER concentrato PER soluzione PER infusione----1件: 19 💬
128Cerezyme® / imiglucerase1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬 		1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
129Cerliponase alfa1件: Cerliponase alfa1件: Cerliponase alfa 💬 1件: TPP1 💬 1件: Lysosome 💬1件: 19 💬
130Cetirizine1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 13, 19, 35 💬
131Challenge agent: capsaicin----1件: 19 💬
132Chemically modified recombinant human sulfamidase----1件: 19 💬
133CHF6657----1件: 19 💬
134Cholecalciferol1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
135Cholesterol1件: Cholesterol1件: Cholesterol 💬 --5件: 19, 90, 160, 222, 310 💬
136Clinimacs® TCR A/ß reagent KIT and clinimacs® CD19 system----3件: 19, 96, 222 💬
137Clofarabine1件: Clofarabine1件: Clofarabine 💬 3件: POLA1,
POLA2,
RRM1 💬 		5件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬5件: 19, 20, 60, 96, 234 💬
138Contrast sensitivity measurement----1件: 19 💬
139Coversyl plus----1件: 19 💬
140Cryopreserved autologous CD34+ cells transduced with A lentiviral vector containing human sgsh gene----1件: 19 💬
141CSA----5件: 19, 49, 60, 63, 222 💬
142Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
143Cyclophosphamide 100 MG/KG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 19, 222 💬
144Cyclophosphamide 1200 MG/KG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 19, 222 💬
145Cyclosporine A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 19, 20, 36, 49, 50, 58, 60, 107, 228, 234, 283 💬
146Cystadane anhydrous----1件: 19 💬
147Cystadrops1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
148Cystadrops 0.55% EYE drops, solution1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
149Cystagon1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--3件: 8, 19, 299 💬
150Cystagon 150MG1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
151Cystagon 50MG1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
152Cysteamine1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--2件: 19, 299 💬
153Cysteamine (mercaptamine) viscous solution1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
154Cysteamine bitartrate1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--4件: 8, 19, 21, 299 💬
155Cysteamine bitartrate (INN: mercaptamine bitartrate1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
156Cysteamine bitartrate delayed-release capsules1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
157Cysteamine hydrochloride1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
158Dapagliflozin 10MG TAB1件: Dapagliflozin1件: Dapagliflozin 💬 --3件: 19, 97, 218 💬
159Deflegmin 75MG, kapsulki O przedluzonym uwalnianiu----1件: 19 💬
160Dexa scan----4件: 19, 46, 96, 299 💬
161Dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 19, 28, 35, 63, 64, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
162DFT383----1件: 19 💬
163Diagnosis OF fabry disease----1件: 19 💬
164Difenidramina cloridrato----3件: 11, 19, 63 💬
165Diphenhydramine1件: Diphenhydramine4件: Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬10件: 13, 19, 49, 51, 70, 86, 96, 222, 256, 300 💬
166DNL126----1件: 19 💬
167DNL310 drug substance----1件: 19 💬
168Dried blood spot (DBS) sampling----1件: 19 💬
169DRX005B----1件: 19 💬
170DUOC-01----3件: 13, 19, 20 💬
171Echocardiogram----3件: 19, 215, 216 💬
172Echocardiography AT M24----1件: 19 💬
173Echocardiography AT T0----1件: 19 💬
174Elaprase1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
175Elaprase 2MG/ML1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
176Elaprase FOR intravenous (IV) infusion----1件: 19 💬
177Elaprase_0.5MG/KG----1件: 19 💬
178Electroencephalogram (EEG) awake and extended overnight----1件: 19 💬
179Elelyso----1件: 19 💬
180Elelyso 60 units/KG----1件: 19 💬
181Elfabrio1件: Pegunigalsidase alfa1件: Pegunigalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
182Eliglustat1件: Eliglustat2件: Eliglustat ,
Eliglustat tartrate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
183Eliglustat GZ3856601件: Eliglustat2件: Eliglustat ,
Eliglustat tartrate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
184Eliglustat tartrate1件: Eliglustat2件: Eliglustat ,
Eliglustat tartrate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
185Eliglustat tartrate capsules1件: Eliglustat2件: Eliglustat ,
Eliglustat tartrate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
186Eliglustat tartrate – powder FOR oral suspension1件: Eliglustat2件: Eliglustat ,
Eliglustat tartrate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
187Elosulfase alfa1件: Elosulfase alfa1件: Elosulfase alfa 💬 1件: GALNS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
188ELX-021件: ELX-02---3件: 19, 218, 299 💬
189Enalapril and other angiotensin converting enzyme inhibitors1件: Enalapril2件: Enalapril maleate ,
Enalapril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 19 💬
190Enriched hematopoetic stem cell infusion----2件: 19, 284 💬
191Enzyme replacement----1件: 19 💬
192Enzyme replacement agent----2件: 19, 256 💬
193Enzyme replacement therapy----1件: 19 💬
194Epidiolex----1件: 19 💬
195ERT----1件: 19 💬
196EU-sourced cerezyme----1件: 19 💬
197Exercise test----1件: 19 💬
198EXG110 injection----1件: 19 💬
199Fabrazyme1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
200Fabrazyme (agalsidase beta) 1 MG/KG1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
201Fabrazyme - 35 MG polvere PER concentrato PER soluzione PER infusione endovenosa 1 flaconcino1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
202Fabrazyme 35 MG1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
203Fabrazyme 5 MG1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
204FBX-1011件: FBX-101---1件: 19 💬
205Fexofenadine1件: Fexofenadine2件: Fexofenadine hydrochloride ,
Fexofenadine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬4件: 6, 13, 19, 46 💬
206FLT1901件: FLT190---1件: 19 💬
207FLT2011件: FLT201---1件: 19 💬
208Fludarabina accord - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 5 flaconcini IN vetro DA 2 ML1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19 💬
209Fludarabina fosfato1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19 💬
210Fludarabine1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬23件: 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
211Fluorescein angiography1件: Fluorescein2件: Fluorescein ,
Fluorescein sodium 💬 		--2件: 19, 41 💬
212GA-GCB1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
213Gabapentin1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬4件: 6, 13, 19, 70 💬
214Galafold1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
215Galsulfase1件: Galsulfase1件: Galsulfase 💬 1件: ARSB 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
216GC1111_0.5MG/KG----1件: 19 💬
217GC1111_1.0MG/KG----1件: 19 💬
218GC1119----1件: 19 💬
219GC1123----1件: 19 💬
220GC1130A----1件: 19 💬
221Gelatine1件: Gelatin2件: Gelatin ,
Donkey glue 💬 		--2件: 19, 296 💬
222Gene activated A-galactosidase A----1件: 19 💬
223Gene activated human glucocerebrosidase----1件: 19 💬
224Gene activated human glucocerebrosidase, velaglucerase alfa1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
225Gene therapy----1件: 19 💬
226GENE-activated human glucocerebrosidase----1件: 19 💬
227GENE-activated human glucocerebrosidase 200U/vial----1件: 19 💬
228GENE-activated human glucocerebrosidase 400U/vial----1件: 19 💬
229General and neurological examination----1件: 19 💬
230Genetic analyses----1件: 19 💬
231Genetic HMI-203----1件: 19 💬
232Genistein aglycone1件: Genistein1件: Genistein 💬 --1件: 19 💬
233GENZ-112638----1件: 19 💬
234GENZ-682452-AA----1件: 19 💬
235GENZ-682452-AU----3件: 6, 19, 67 💬
236GLA gene----1件: 19 💬
237Glucocerebrosidase----1件: 19 💬
238Glucocerebrosidase umano GENE-attivato----1件: 19 💬
239GNR-055----1件: 19 💬
240GNR-055 1.0-2.0-3.0 MG/KG----1件: 19 💬
241GNR-055 2.0 MG/KG----1件: 19 💬
242GNR-055 3.0 MG/KG----1件: 19 💬
243GR181413----1件: 19 💬
244GR181413A----1件: 19 💬
245GR181413A/AT1001 capsule----1件: 19 💬
246GR181413A/AT1001 solution----1件: 19 💬
247Growth hormone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬16件: 2, 19, 46, 77, 78, 96, 97, 107, 113, 156, 191, 193, 195, 238, 265, 299 💬
248GSK2788723----1件: 19 💬
249GZ/SAR402671----2件: 19, 67 💬
250GZ385660----1件: 19 💬
251GZ402665----1件: 19 💬
252GZ402671----1件: 19 💬
253GZ402671 / SAR402671----1件: 19 💬
254Hematopoetic stem cell transplantation----6件: 19, 65, 121, 160, 308, 326 💬
255Hematopoietic stem cell infusion----2件: 19, 20 💬
256Hematopoietic stem cell transplantation----13件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
257HeparáN N sulfatasa humana recombinante----1件: 19 💬
258HGT-1110----1件: 19 💬
259HGT-1111----1件: 19 💬
260HGT-1410----1件: 19 💬
261HGT-2310----1件: 19 💬
262High dose AT-GTX-502----1件: 19 💬
263HM15421/GC1134A----1件: 19 💬
264Hucns-SC----1件: 19 💬
265Human glucocerebrosidase cdna----1件: 19 💬
266Human glucocerebrosidase gene into autologous peripheral blood stem cells----1件: 19 💬
267Human N-sulfoglucosamine sulfohydrolase fused TO A humanised monoclonal antibody targeting human transferrin receptor----1件: 19 💬
268Human placental derived stem cell----4件: 19, 20, 60, 284 💬
269Hunterase1件: Idursulfase beta1件: Idursulfase beta 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
270Hydroxypropyl-BETA-cyclodextrin----1件: 19 💬
271Hydroxypropyl-ß-cyclodextrin----1件: 19 💬
272Hydroxyurea1件: Hydroxyurea1件: Hydroxyurea 💬 1件: RRM2 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬10件: 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
273I2S----1件: 19 💬
274I2S-IT----1件: 19 💬
275IB1001----2件: 19, 65 💬
276Iduronate-2-sulfatase enzyme replacement therapy----1件: 19 💬
277Iduronate-2-sulfatase fused TO A FC polypeptide that binds TO THE human transferrin receptor----1件: 19 💬
278Idursulfasa1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
279Idursulfase1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
280Idursulfase (I2S)-IT1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
281Idursulfase beta2件: Idursulfase,
Idursulfase beta		2件: Idursulfase ,
Idursulfase beta 💬 		1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
282Idursulfase(12S)-IT1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
283Idursulfase(I2S)-IT1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
284Idursulfase-IT1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
285Idursulfasi----1件: 19 💬
286IMD preparative regimen----5件: 19, 20, 125, 234, 326 💬
287Imiglucerasa1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬 		1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
288Imiglucerase1件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬 		1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
289Imiglucerase GZ4378431件: Imiglucerase2件: Alglucerase ,
Imiglucerase 💬 		1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
290Imiglucerasi----1件: 19 💬
291Imiglucérase (drug) pharmacokinetics----1件: 19 💬
292Inactive reminder capsules----1件: 19 💬
293Inactive reminder product----1件: 19 💬
294INN NOT available----2件: 19, 46 💬
295Innozide----1件: 19 💬
296Intracerebral administration OF aavrh.10cuarsa----1件: 19 💬
297Intrathecal recombinant human alpha iduronidase----1件: 19 💬
298Intraventricular access device----1件: 19 💬
299Iohexol1件: Iohexol1件: Iohexol 💬 --2件: 19, 67 💬
300IRT laronidase----1件: 19 💬
301Isaralgagene civaparvovec1件: Isaralgagene civaparvovec---1件: 19 💬
302Isofagamine tartrate----1件: 19 💬
303ISU302----1件: 19 💬
304IV migalastat HCL----1件: 19 💬
305IVA 336----1件: 19 💬
306Izcargo----1件: 19 💬
307JR-141----1件: 19 💬
308JR-141 or idursulfase1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
309JR-171----1件: 19 💬
310JR-441----1件: 19 💬
311JR-446----1件: 19 💬
312JWK008 single intravenous infusion administration----1件: 19 💬
313Kanuma1件: Sebelipase alfa1件: Sebelipase alfa 💬 1件: LIPA 💬 4件: Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬1件: 19 💬
314Ketogenic diet----9件: 13, 19, 21, 49, 67, 77, 127, 145, 148 💬
315Kidney transplant----2件: 19, 222 💬
316Laboratory tests----3件: 19, 113, 256 💬
317Lamazym1件: Velmanase alfa1件: Velmanase alfa 💬 1件: MAN2B1 💬 2件: Lysosome, Other glycan degradation 💬1件: 19 💬
318Laronidase1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome 💬2件: 19, 256 💬
319Laronidase ERT1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
320Laronidase therapy and A stem cell transplant1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
321Ledipasvir/sofosbuvir1件: Ledipasvir1件: Ledipasvir 💬 --1件: 19 💬
322Lenograstim1件: Lenograstim1件: Lenograstim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬8件: 2, 13, 16, 18, 19, 57, 65, 97 💬
323Lentivirus alpha-GAL A transduced stem cells----1件: 19 💬
324Lepunafusp alfa1件: Lepunafusp alfa---1件: 19 💬
325Leucovorin1件: Leucovorin3件: Leucovorin calcium ,
Folinic acid ,
Folinic acid calcium salt pentahydrate 💬 		--2件: 19, 46 💬
326Lisinopril1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬5件: 19, 46, 66, 67, 113 💬
327Lopace----1件: 19 💬
328Loratadine1件: Loratadine1件: Loratadine 💬 1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 13, 19, 46, 89, 98 💬
329Losartan1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬15件: 17, 19, 46, 58, 66, 67, 85, 96, 97, 113, 164, 167, 215, 222, 299 💬
330Losartan and other angiotensin receptor blockers1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 19 💬
331LOW dose AT-GTX-502----1件: 19 💬
332Lucerastat1件: Lucerastat1件: Lucerastat 💬 1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
333Lumbar puncture----6件: 6, 13, 19, 96, 97, 127 💬
334LY-M001----1件: 19 💬
335LY-M001 injection----1件: 19 💬
336LY38849611件: LY3884961---2件: 6, 19 💬
337Lymphocyte gene therapy----1件: 19 💬
338LYS-GM101----1件: 19 💬
339LYS-SAF3021件: Olenasufligene relduparvovec---1件: 19 💬
340Lysodase1件: PEG-Glucocerebrosidase---1件: 19 💬
341Mabthera - 2 fiale 100 MG 10 ML1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 19, 65 💬
342Magnetic resonance imaging----11件: 13, 19, 22, 28, 34, 46, 65, 205, 285, 299, 344 💬
343Mechanical stimulation with VON frey filaments----1件: 19 💬
344Medication TO suppress THE immune system----1件: 19 💬
345Melphalan1件: Melphalan2件: Melphalan ,
Melphalan hydrochloride 💬 		--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
346Mepsevii----1件: 19 💬
347Mercaptamina1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
348Mercaptamine1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
349Mercaptamine bitartrate1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
350Mercaptamine hydrochloride1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
351Mercaptamine, mercamine, 2-aminoethanethiol1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
352Metazym----1件: 19 💬
353Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬37件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
354Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
355Migalastat1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
356Migalastat HCL1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
357Migalastat HCL 150 MG1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
358Migalastat HCL 20 MG1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
359Migalastat hydrochloride1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
360Migalastat hydrocloride1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
361Miglustat1件: Miglustat1件: Miglustat 💬 1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬3件: 19, 256, 299 💬
362Montelukast1件: Montelukast2件: Montelukast sodium ,
Montelukast 💬 		1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬9件: 6, 13, 19, 46, 61, 63, 85, 98, 228 💬
363MRI with contrast agent injection----1件: 19 💬
364MRI without contrast agent injection----1件: 19 💬
365Mucoangin----1件: 19 💬
366Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬32件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
367Mycophenylate mofetil----2件: 19, 20 💬
368Myelostim - 34 1 flaconcino liofilizzato 33.6 MIU + siringa preriempita solvente 1 ML----2件: 19, 65 💬
369N acetyl cysteine----2件: 6, 19 💬
370N acetyl L leucine----1件: 19 💬
371N-acetyl-L leucine----1件: 19 💬
372N-acetyl-L-leucine1件: L-Acetylleucine---2件: 19, 65 💬
373N-acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬 --14件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
374N-acetylcysteine amide----1件: 19 💬
375N-acetylgalactosamine 4-sulfatase----1件: 19 💬
376Naglazyme1件: Galsulfase1件: Galsulfase 💬 1件: ARSB 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
377Neurocognitive testing----1件: 19 💬
378Neurology exam----1件: 19 💬
379NGN-1011件: NGN-101---1件: 19 💬
380NO investigational product----1件: 19 💬
381NO IT treatment----1件: 19 💬
382NON applicable----2件: 10, 19 💬
383Odiparcil1件: Odiparcil---1件: 19 💬
384OGT 918----2件: 19, 299 💬
385OGT918----1件: 19 💬
386OGT923----1件: 19 💬
387Olenasufligene relduparvovec1件: Olenasufligene relduparvovec---1件: 19 💬
388Olipudase alfa1件: Olipudase alfa1件: Olipudase alfa 💬 1件: SMPD1 💬 4件: Lysosome, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬1件: 19 💬
389Omnipaque1件: Iohexol1件: Iohexol 💬 --2件: 19, 222 💬
390Ophthalmology exam----1件: 19 💬
391Optimized prophylactic IM therapy----1件: 19 💬
392Oral migalastat HCL----1件: 19 💬
393Osome----1件: 19 💬
394Osteopetrosis haploidentical only preparative regimen----5件: 19, 20, 125, 234, 326 💬
395Osteopetrosis only preparative regimen----5件: 19, 20, 125, 234, 326 💬
396OTL-200----1件: 19 💬
397OTL-200 dispersion FOR infusion----1件: 19 💬
398OTL-200 gene therapy----1件: 19 💬
399OTL-2031件: OTL-203---1件: 19 💬
400Oxygen flow AT THE optic nerve head measurement1件: Oxygen1件: Oxygen 💬 --1件: 19 💬
401Pabinafusp alfa1件: Pabinafusp alfa1件: Pabinafusp alfa 💬 2件: IDS,
TFRC 💬 		9件: Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Phagosome, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬1件: 19 💬
402Palliative care----6件: 19, 65, 121, 160, 308, 326 💬
403Paracetamolo DOC generici - 1000 MG compressa 16 compresse----1件: 19 💬
404Paricalcitol1件: Paricalcitol1件: Paricalcitol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 19, 66, 218, 238, 298 💬
405PBGM011件: PBGM01---1件: 19 💬
406PBKR031件: PBKR03---1件: 19 💬
407Pegunigalsidase alfa1件: Pegunigalsidase alfa1件: Pegunigalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
408Pegunigalsidase alpha----1件: 19 💬
409Pegunigalsidase-alfa----1件: 19 💬
410Pending----7件: 6, 13, 19, 96, 97, 113, 302 💬
411Pentosan polysulfat SP 54® injection solution----1件: 19 💬
412Pentosan polysulfate sodium1件: Pentosan polysulfate1件: Pentosan polysulfate sodium 💬 --1件: 19 💬
413Pentosan polysulphate SP54----1件: 19 💬
414Perdix----1件: 19 💬
415Picc or other central line placement----1件: 19 💬
416Plant cell recombinant glucocerebrosidase----1件: 19 💬
417PLX-200----1件: 19 💬
418Potable water----1件: 19 💬
419Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
420Prednisone DOC generici - 5 MG compresse 10 compresse IN blister PVC-pvdc/ALU1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 19 💬
421Prevenar13----2件: 19, 265 💬
422Prgcd1件: Taliglucerase alfa1件: Taliglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
423Procysbi1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--1件: 19 💬
424Prophylactic immunomodulatory (IM) therapy----1件: 19 💬
425PRX-102----1件: 19 💬
426PRX-102 1 MG/KG every 2 weeks----1件: 19 💬
427PRX-102 1 MG/KG every TWO weeks----1件: 19 💬
428PRX-102 2 MG/KG every 4 weeks----1件: 19 💬
429PRX-112----1件: 19 💬
430PRX102----1件: 19 💬
431PTC124----4件: 19, 113, 246, 299 💬
432Purified form OF THE lysosomal enzyme iduronate-2-sulfatase----1件: 19 💬
433Pyrimethamine1件: Pyrimethamine1件: Pyrimethamine 💬 --4件: 2, 4, 19, 65 💬
434Quality OF life questionnaire----1件: 19 💬
435Raav 2/6 hids donor----1件: 19 💬
436RAAV2/5-hnaglu----1件: 19 💬
437RAAV2/6 left ZFN vector----1件: 19 💬
438RAAV2/6 right ZFN vector----1件: 19 💬
439RAAV9.CMV.hnaglu----1件: 19 💬
440Rebisufligene etisparvovec1件: Rebisufligene etisparvovec---1件: 19 💬
441Recombinant adeno-associated virus 2/6 vector encoding THE cdna FOR human alpha galactosidase A----1件: 19 💬
442Recombinant alpha-galactosidase A1件: Agalsidase alfa1件: Agalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
443Recombinant human acid sphingomyelinase----1件: 19 💬
444Recombinant human alpha-galactosidase----1件: 19 💬
445Recombinant human alpha-galactosidase abbreviated AS R-H-alpha-GAL----1件: 19 💬
446Recombinant human alpha-mannosidase----1件: 19 💬
447Recombinant human arylsulfatase A1件: Recombinant human arylsulfatase A---1件: 19 💬
448Recombinant human arysulfatase B, recombinant human N-acetylgalactosamine 4-sulfatase----1件: 19 💬
449Recombinant human beta glucuronidase----1件: 19 💬
450Recombinant human BETA-glucuronidase1件: Vestronidase alfa1件: Vestronidase alfa 💬 1件: uidA 💬 6件: Ascorbate and aldarate metabolism, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Pentose and glucuronate interconversions, Porphyrin metabolism 💬1件: 19 💬
451Recombinant human betaglucuronidase----1件: 19 💬
452Recombinant human derived macrophage-targeted ß-glucocerebrosidase----1件: 19 💬
453Recombinant human glucerebrosidase----1件: 19 💬
454Recombinant human glucocerebrosidase----1件: 19 💬
455Recombinant human heparan N-sulfatase----1件: 19 💬
456Recombinant human lysosomal acid lipase----1件: 19 💬
457Recombinant human lysosomal alpha-mannosidase----1件: 19 💬
458Recombinant human N-acetylgalactosamine 4-sulfatase----1件: 19 💬
459Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110----1件: 19 💬
460Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 1101件: Elosulfase alfa1件: Elosulfase alfa 💬 1件: GALNS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
461Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance1件: Elosulfase alfa1件: Elosulfase alfa 💬 1件: GALNS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
462Recombinant human tripeptidyl peptidase-11件: Cerliponase alfa1件: Cerliponase alfa 💬 1件: TPP1 💬 1件: Lysosome 💬1件: 19 💬
463Recombinant SELF-complementary adeno-associated viral vector serotype 9 containing THE human CLN6 gene----1件: 19 💬
464Reduced intensity conditioning----2件: 19, 65 💬
465Reminder capsules----1件: 19 💬
466Reminder product----1件: 19 💬
467Replagal1件: Agalsidase alfa1件: Agalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
468Replagal agalsidase alfa1件: Agalsidase alfa1件: Agalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
469RGX-1111件: RGX-111---1件: 19 💬
470RGX-1211件: RGX-121---1件: 19 💬
471RH growth hormone----1件: 19 💬
472Rharsa----1件: 19 💬
473Rhasa----1件: 19 💬
474Rhasa - dose level 1----1件: 19 💬
475Rhasa - dose level 2----1件: 19 💬
476Rhasa - dose level 3----1件: 19 💬
477Rhasa [recombinant human arylsulfatase A], formerly HGT-1110, NOW also known AS TAK-611----1件: 19 💬
478Rhasm----1件: 19 💬
479Rhgalns1件: Elosulfase alfa1件: Elosulfase alfa 💬 1件: GALNS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
480Rhgus----1件: 19 💬
481Rhhns1件: Heparan-N-sulfatase (human, recombinant)---1件: 19 💬
482Rhhns-10 MG1件: Heparan-N-sulfatase (human, recombinant)---1件: 19 💬
483Rhhns-45 MG1件: Heparan-N-sulfatase (human, recombinant)---1件: 19 💬
484Rhhns-90 MG1件: Heparan-N-sulfatase (human, recombinant)---1件: 19 💬
485Rhlaman1件: Velmanase alfa1件: Velmanase alfa 💬 1件: MAN2B1 💬 2件: Lysosome, Other glycan degradation 💬1件: 19 💬
486Rhnaglu----1件: 19 💬
487Rhnaglu radiolabelled----1件: 19 💬
488Rhnaglu-IGF21件: Tralesinidase alfa---1件: 19 💬
489Rimiducid1件: Rimiducid1件: Rimiducid 💬 1件: CASP9 💬 34件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬7件: 19, 49, 60, 65, 284, 285, 326 💬
490Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
491Rivogenlecleucel1件: Rivogenlecleucel1件: Rivogenlecleucel 💬 --6件: 19, 60, 65, 284, 285, 326 💬
492RP 103----2件: 8, 19 💬
493RP103----2件: 8, 19 💬
494RVX000222----1件: 19 💬
495SAF-301----1件: 19 💬
496Saline solution FOR injection----1件: 19 💬
497SAR402671, GZ402671 or GZ / SAR402671----1件: 19 💬
498SAR402671, GZ402671 or GZ/SAR402671----3件: 6, 19, 67 💬
499SB-318----1件: 19 💬
500SB-47171----1件: 19 💬
501SB-47898----1件: 19 💬
502SB-913----1件: 19 💬
503SB-A6P-HRL donor vector----1件: 19 💬
504SB-FIX----1件: 19 💬
505SB-idua----1件: 19 💬
506SBC-1021件: Sebelipase alfa1件: Sebelipase alfa 💬 1件: LIPA 💬 4件: Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬1件: 19 💬
507SBC-102, recombinant human lysosomal acid lipase1件: Sebelipase alfa1件: Sebelipase alfa 💬 1件: LIPA 💬 4件: Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬1件: 19 💬
508SBC-1031件: Lesinidase alfa1件: Lesinidase alfa 💬 1件: NAGLU 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
509Scaav9.CB.CLN6----1件: 19 💬
510Scaav9.U1A.hsgsh1件: Rebisufligene etisparvovec---1件: 19 💬
511Scaav9.U1A.sgsh----1件: 19 💬
512Sebelipase alfa1件: Sebelipase alfa1件: Sebelipase alfa 💬 1件: LIPA 💬 4件: Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬1件: 19 💬
513Sebelipase alfa 0.35 MG/KG1件: Sebelipase alfa1件: Sebelipase alfa 💬 1件: LIPA 💬 4件: Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬1件: 19 💬
514Sebelipase alfa 1 MG/KG1件: Sebelipase alfa1件: Sebelipase alfa 💬 1件: LIPA 💬 4件: Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬1件: 19 💬
515Sebelipase alfa 3 MG/KG1件: Sebelipase alfa1件: Sebelipase alfa 💬 1件: LIPA 💬 4件: Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬1件: 19 💬
516SHP611----1件: 19 💬
517SHP675----1件: 19 💬
518Sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬39件: 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
519Skeletal survey----1件: 19 💬
520Skin biopsy----4件: 6, 19, 21, 84 💬
521Slit lamp assessment and intra-ocular pressure measurement----1件: 19 💬
522SOBI003----1件: 19 💬
523Somatropin1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬18件: 2, 3, 19, 74, 75, 78, 96, 97, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬
524Speech and modified barium swallow study----1件: 19 💬
525ST-920----1件: 19 💬
526Stem cell transplant----7件: 19, 20, 60, 65, 96, 164, 284 💬
527Stem cell transplantation----13件: 13, 19, 20, 46, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
528SUB195712----1件: 19 💬
529TAK-675----1件: 19 💬
530Taliglucerase alfa1件: Taliglucerase alfa1件: Taliglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
531Taliglucerase alfa - recombinant human glucocerebrosidase1件: Taliglucerase alfa1件: Taliglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
532TBD----5件: 19, 86, 90, 276, 299 💬
533Temperature sensitivity measurement with advanced thermal stimulation----1件: 19 💬
534Thiotepa--escalated dose1件: Thiotepa1件: Thiotepa 💬 --4件: 19, 20, 65, 284 💬
535Thiotepa--single daily dose1件: Thiotepa1件: Thiotepa 💬 --4件: 19, 20, 65, 284 💬
536Tividenofusp alfa1件: Tividenofusp alfa1件: Tividenofusp alfa 💬 2件: IDS,
TFRC 💬 		9件: Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Phagosome, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬1件: 19 💬
537Total body irradiation----13件: 19, 20, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284, 285 💬
538Total body irradiation with marrow boosting----2件: 19, 234 💬
539Tralesinidase alfa1件: Tralesinidase alfa---1件: 19 💬
540Transduced CD34+ hematopoietic stem cell----2件: 19, 20 💬
541Trappsol cyclo----1件: 19 💬
542Treosulfan1件: Treosulfan1件: Treosulfan 💬 --6件: 13, 19, 62, 65, 284, 286 💬
543Triapin& triapin mite----1件: 19 💬
544Tropicamide1件: Tropicamide1件: Tropicamide 💬 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 19 💬
545TSHA-1011件: TSHA-101---1件: 19 💬
546TTX-381----1件: 19 💬
547Unrelated umbilical cord blood transplant----1件: 19 💬
548Uplyso----1件: 19 💬
549Urine collection----3件: 19, 215, 216 💬
550Usan: sebelipasa alfa1件: Sebelipase alfa1件: Sebelipase alfa 💬 1件: LIPA 💬 4件: Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬1件: 19 💬
551Usan: sebelipase alpha----1件: 19 💬
552UX003----1件: 19 💬
553UX1111件: Rebisufligene etisparvovec---1件: 19 💬
554Vector viral adenoasociado DE serotipo 9 QUE contiene EL GEN DE LA sulfamidasa humana----1件: 19 💬
555Velaglucerase alfa1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
556Velaglucerasi alfa----1件: 19 💬
557Velmanase alfa1件: Velmanase alfa1件: Velmanase alfa 💬 1件: MAN2B1 💬 2件: Lysosome, Other glycan degradation 💬1件: 19 💬
558Venglustat1件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬2件: 19, 67 💬
559Venglustat GZ4026711件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬2件: 19, 67 💬
560Venglustat L-malate1件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
561Venglustat malate1件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬3件: 6, 19, 67 💬
562Venglustat malato1件: Venglustat2件: Venglustat ,
Venglustat malate 💬 		1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬2件: 19, 67 💬
563Verenafusp alfa 12 MG/KG----1件: 19 💬
564Verenafusp alfa 6 MG/KG----1件: 19 💬
565Verenafusp alfa 9 MG/KG----1件: 19 💬
566Vestronidase alfa1件: Vestronidase alfa1件: Vestronidase alfa 💬 1件: uidA 💬 6件: Ascorbate and aldarate metabolism, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Pentose and glucuronate interconversions, Porphyrin metabolism 💬1件: 19 💬
567VGN-R08B----1件: 19 💬
568Visual field testing----1件: 19 💬
569Vital signs----4件: 3, 15, 19, 256 💬
570Vitamin D1件: Vitamin D---20件: 6, 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 299 💬
571Vitamin E1件: Vitamin E1件: Vitamin E 💬 --5件: 2, 19, 20, 90, 206 💬
572Vosoritide1件: Vosoritide1件: Vosoritide 💬 1件: NPR2 💬 5件: Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 19, 276 💬
573Vpriv1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
574Vpriv - 400 U - polvere PER soluzione PER infusione - USO endovenoso - flaconcino(vetro) 1 flaconcino1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
575Vpriv 400 units powder FOR solution OF infusion1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
576VTS-270----1件: 19 💬
577Warfarin1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬10件: 6, 8, 19, 46, 49, 66, 85, 86, 88, 91 💬
578Water1件: Water1件: Water 💬 --25件: 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬
579Whole body protein turnover----4件: 19, 46, 96, 299 💬
580Zavesca1件: Miglustat1件: Miglustat 💬 1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬3件: 19, 256, 299 💬
581Zavesca 84CPS 100MG1件: Miglustat1件: Miglustat 💬 1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
582Zestoretic 10,201件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 19 💬
583Zestoric----1件: 19 💬
584Zestril1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬3件: 19, 67, 222 💬